- Latest available (Revised)
- Point in Time (06/06/2005)
- Original (As adopted by EU)
Commission Directive 2005/38/EC of 6 June 2005 laying down the sampling methods and the methods of analysis for the official control of the levels of Fusarium toxins in foodstuffs (Text with EEA relevance) (repealed)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.
As the distribution of Fusarium toxins is non-homogeneous, samples shall be prepared, and especially homogenised, with extreme care.
All the material received by the laboratory must be used for the preparation of test material.
Each laboratory sample must be finely grinded and mixed thoroughly using a process that has been demonstrated to achieve complete homogenisation.
In case the maximum level applies to the dry matter, the dry matter content of the product shall be determined on a part of the homogenised sample, using a procedure that has been demonstrated to determine accurately the dry matter content.
The replicate samples for enforcement, trade (defence) and referee purposes shall be taken from the homogenised material unless such procedure conflicts with Member States’ rules on sampling.
A number of the most commonly used definitions that the laboratory shall be required to use are the following:
The most commonly quoted precision parameters are repeatability and reproducibility.
=
Repeatability, the value below which the absolute difference between two single test results obtained under repeatability conditions, namely same sample, same operator, same apparatus, same laboratory, and short interval of time may be expected to lie within a specific probability (typically 95 %) and hence r = 2,8 × sr
=
Standard deviation, calculated from results generated under repeatability conditions
=
Reproducibility, the value below which the absolute difference between single test results obtained under reproducibility conditions, namely on identical material obtained by operators in different laboratories, using the standardised test method may be expected to lie within a certain probability (typically 95 %); R = 2,8 × sR
=
Standard deviation, calculated from results under reproducibility conditions
=
Relative standard deviation calculated from results generated under reproducibility conditions .
Methods of analysis used for food control purposes must comply with the provisions of items 1 and 2 of the Annex to Directive 85/591/EEC.
Where no specific methods for the determination of Fusarium toxins levels in foodstuffs are required by Community legislation, laboratories may select any method provided the selected method meets the following criteria:
Performance characteristics for deoxynivalenol
Level μg/kg | Deoxynivalenol | ||
---|---|---|---|
RSDr % | RSDR % | Recovery % | |
> 100-≤ 500 | ≤ 20 | ≤ 40 | 60 to 110 |
> 500 | ≤ 20 | ≤ 40 | 70 to 120 |
Performance characteristics for zearalenone
Level μg/kg | Zearalenone | ||
---|---|---|---|
RSDr % | RSDR % | Recovery % | |
≤ 50 | ≤ 40 | ≤ 50 | 60 to 120 |
> 50 | ≤ 25 | ≤ 40 | 70 to 120 |
Performance characteristics for Fumonisin B1 and B2
Level μg/kg | Fumonisin B1 or B2 | ||
---|---|---|---|
RSDr % | RSDR % | Recovery % | |
≤ 500 | ≤ 30 | ≤ 60 | 60 to 120 |
> 500 | ≤ 20 | ≤ 30 | 70 to 110 |
Performance characteristics for T-2 and HT-2 toxin
Level μg/kg | T-2 toxin | ||
---|---|---|---|
RSDr % | RSDR % | Recovery % | |
50-250 | ≤ 40 | ≤ 60 | 60 to 130 |
> 250 | ≤ 30 | ≤ 50 | 60 to 130 |
Level μg/kg | HT-2 toxin | ||
---|---|---|---|
RSDr % | RSDR % | Recovery % | |
100-200 | ≤ 40 | ≤ 60 | 60 to 130 |
> 200 | ≤ 30 | ≤ 50 | 60 to 130 |
The detection limits of the methods used are not stated as the precision values are given at the concentrations of interest.
The precision values are calculated from the Horwitz equation:
RSDR = 2(1-0,5logC)
where:
RSDR is the relative standard deviation calculated from results generated under reproducibility conditions
C is the concentration ratio (i.e. 1 = 100 g/100 g, 0,001 = 1 000 mg/kg
That is a generalised precision equation, which has been found to be independent of analyte and matrix but solely dependent on concentration for most routine methods of analysis.
In the case where there are a limited number of fully validated methods of analysis, alternatively, a ‘fitness-for-purpose’ approach, defining a single parameter, a fitness function, to evaluate the acceptability of methods of analysis may be used. A fitness function is an uncertainty function that specifies maximum levels of uncertainty regarded as fit for purpose.
Given the limited number of methods of analysis, fully validated by a collaborative trial, especially for the determination of T-2 and HT-2 toxin, the uncertainty function approach, specifying the maximum acceptable uncertainty, may also be used to assess the suitability (the ‘fitness-for-purpose’) of the method of analysis to be used by the laboratory. The laboratory may use a method which produces results within the maximum standard uncertainty. The maximum standard uncertainty may be calculated using the following formula:
where:
Uf is the maximum standard uncertainty (μg/kg)
LOD is the limit of detection of the method (μg/kg)
α is a constant, numeric factor to be used depending on the value of C. The values to be used are set out in Table 3
C is the concentration of interest (μg/kg).
If the analytical method provides results with uncertainty measurements less than the maximum standard uncertainty the method shall be considered being equally suitable to one which meets the performance characteristics given in point 4.3.1.
Numeric values to be used for α as constant in formula set out in this point, depending on the concentration of interest
C (μg/kg) | α |
---|---|
≤ 50 | 0,2 |
51-500 | 0,18 |
501-1 000 | 0,15 |
1 001-10 000 | 0,12 |
> 10 000 | 0,1 |
The analytical result must be reported corrected or uncorrected for recovery. The manner of reporting and the level of recovery must be reported. The analytical result corrected for recovery shall be used for checking compliance (see Annex I, point 5).
The analytical result must be reported as x +/– U whereby x is the analytical result and U is the expanded measurement uncertainty.
U is the expanded uncertainty, using a coverage factor of 2 which gives a level of confidence of approximately 95 %.
Laboratories must comply with Council Directive 93/99/EEC.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: